See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
scleroderma. The first signs of the disease are reddish patches of skin that thicken into firm, oval-shaped areas. The center of each patch becomes ivory colored with violet borders. These patches sweat very little and have little hair growth. Patches appear most often on the chest, stomach, and back. Sometimes they appear on the face, arms, and legs. In most cases, morphea improves spontaneously over time (typically 3 to 5 years); however, affected people are often left with patches of darkened or discolored skin and, in rare cases, muscle damage. The cause of this condition is unknown. Management is based on the signs and symptoms present in each person and includes the use of corticosteroids.Morphea (mor-FEE-ah) refers to localized patches of
Last updated: 2/10/2016
- Scleroderma. National Institute of Musculoskeletal and Skin Diseases (NIAMS). 2006; http://www.niams.nih.gov/Health_Info/Scleroderma/default.asp. Accessed 1/28/2010.
- What is Scleroderma?. Scleroderma Research Foundation. 2006; http://www.srfcure.org/for-patients/what-is-scleroderma. Accessed 1/28/2010.
- Morphea. MayoClinic.com. 2008; http://www.mayoclinic.com/print/morphea/DS00718/DSECTION=all&METHOD=print. Accessed 1/28/2010.
- Localized morphea. Orphanet. 2010; http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=12000.
- DermNet NZ is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.
- MedlinePlus was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases, the training of basic and clinical scientists to carry out this research, and the dissemination of information on research progress in these diseases. Click on the link to view information on this topic.
- The National Organization for Rare Disorders (NORD) is a federation of more than 130 nonprofit voluntary health organizations serving people with rare disorders. Click on the link to view information on this topic.
- Select volumes of the Scleroderma Care and Research Journal can be viewed by visiting the Scleroderma Clinical Trials Consortium Web site. Click on the link above to learn more.